EVAX
Evaxion Biotech AS
NASDAQ: EVAX · HEALTHCARE · BIOTECHNOLOGY
$4.41
+3.52% today
Updated 2026-04-30
Market cap
$33.61M
P/E ratio
—
P/S ratio
4.47x
EPS (TTM)
$-1.00
Dividend yield
—
52W range
$1 – $12
Volume
0.0M
Evaxion Biotech AS (EVAX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $2.95M | $8.51M | $11.08M | $11.96M | $40.16M | $22.02M | $12.89M | $12.48M |
| Cash & equivalents | $468000.00 | $7.43M | $9.56M | $5.83M | $32.17M | $13.18M | $5.58M | $5.05M |
| Current assets | $2.74M | $8.38M | $10.96M | $10.95M | $34.70M | $16.98M | $8.35M | $8.77M |
| Total liabilities | $399000.00 | $9.44M | $1.72M | $4.93M | $7.73M | $13.72M | $17.62M | $14.14M |
| Current liabilities | $303000.00 | $9.42M | $1.72M | $4.93M | $4.32M | $3.76M | $7.08M | $4.37M |
| Long-term debt | — | — | — | — | $1.04M | $7.86M | $8.49M | $8.01M |
| Shareholder equity | $2.55M | $-931000.00 | $9.36M | $7.04M | $32.44M | $8.30M | $-4.73M | $-1.65M |
| Retained earnings | $-3.51M | $-6.98M | $-15.81M | $-27.28M | $-50.43M | $-85.84M | $-107.97M | $-118.54M |
| Accounts receivable | $2.14M | $772000.00 | $931000.00 | $1.79M | $1.90M | $1.31M | $1.07M | $1.86M |
| Inventory | — | $-1.36M | $-6.00 | $-6.91M | $-1.90M | $-2.49M | — | — |
| Goodwill | — | — | — | — | — | — | — | — |